The World Health Organization’s (WHO) response to COVID-19 was too slow, hampered by an antiquated pandemic alert system, lack of resources and a lack of authority with member states, according to an interim report by the Independent Panel on Pandemic Preparedness and Response, presented to the WHO’s Executive Board meeting on Tuesday. It took the […] Continue reading ->
A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading ->
Moderna’s mRNA COVID-19 vaccine appears to be able to reduce infection and therefore transmission of the virus, a Harvard expert has told Health Policy Watch, albeit despite the currently limited data sets. Although both vaccines appear to have incredibly high efficacy (94.1% for Moderna and 95% for Pfizer) in terms of preventing those vaccinated from […] Continue reading ->
Following months of delay, and delicate backdoor negotiations, WHO now says that it “hopes” an international team has been mandated by the World Health Assembly to investigate the sources of the SARS-CoV2 virus can travel to China in January to begin their fieldwork.   “The International team is currently working on logistical arrangements to travel to […] Continue reading ->
The combined health and economic shocks triggered by COVID-19 have revealed profound weaknesses in health systems, with direct consequences on the future of healthcare, says a new World Health Organisation report on global health financing systems.  “COVID-19 has revealed [the] underlying weakness of country and global health financing systems. There needs to be a proactive […] Continue reading ->
The economic benefits to the economies of ten high income countries being asked to support the equitable, worldwide distribution of COVID-19 vaccines, treatments and tests would be 12 times the costs, a new report has found. The study, undertaken by the global political risk research firm Eurasia Group, on behalf of the Bill and Melinda […] Continue reading ->